Shareholder Blue Chip Partners Has Increased Verizon Communications I (VZ) Stake; Weiss Asset Management LP Has Trimmed Its Ani Pharmaceuticals (ANIP) Position by $9.18 Million as Valuation Declined

May 21, 2018 - By Ellis Scott

Verizon Communications Inc. (NYSE:VZ) Logo

Andrew Weiss decreased its stake in Ani Pharmaceuticals Inc (ANIP) by 92.5% based on its latest 2017Q4 regulatory filing with the SEC. Weiss Asset Management Lp sold 143,450 shares as the company’s stock declined 8.99% with the market. The hedge fund run by Andrew Weiss held 11,639 shares of the health care company at the end of 2017Q4, valued at $750,000, down from 155,089 at the end of the previous reported quarter. Weiss Asset Management Lp who had been investing in Ani Pharmaceuticals Inc for a number of months, seems to be less bullish one the $759.40 million market cap company. The stock decreased 0.28% or $0.18 during the last trading session, reaching $64.43. About 44,948 shares traded. ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) has risen 18.93% since May 21, 2017 and is uptrending. It has outperformed by 7.38% the S&P500.

Blue Chip Partners Inc increased its stake in Verizon Communications I (VZ) by 4.94% based on its latest 2017Q4 regulatory filing with the SEC. Blue Chip Partners Inc bought 7,217 shares as the company’s stock declined 11.05% with the market. The hedge fund held 153,294 shares of the telecommunications equipment company at the end of 2017Q4, valued at $8.11M, up from 146,077 at the end of the previous reported quarter. Blue Chip Partners Inc who had been investing in Verizon Communications I for a number of months, seems to be bullish on the $197.26B market cap company. The stock decreased 0.23% or $0.11 during the last trading session, reaching $47.74. About 11.38 million shares traded. Verizon Communications Inc. (NYSE:VZ) has declined 3.72% since May 21, 2017 and is downtrending. It has underperformed by 15.27% the S&P500.

More notable recent Verizon Communications Inc. (NYSE:VZ) news were published by: Globenewswire.com which released: “My Verizon App is now available en español” on May 01, 2018, also 247Wallst.com with their article: “Is Verizon Back on Track?” published on April 24, 2018, 247Wallst.com published: “Why Verizon’s Earnings May Be Under a Cloud” on April 23, 2018. More interesting news about Verizon Communications Inc. (NYSE:VZ) were released by: Fool.com and their article: “Verizon Aims to Be Much More Than a Phone Company” published on May 10, 2018 as well as Benzinga.com‘s news article titled: “JPMorgan: Verizon On ‘Stable Footing’ As 5G Opportunity Crystallizes” with publication date: May 11, 2018.

Since February 13, 2018, it had 0 buys, and 2 selling transactions for $444,552 activity.

Among 31 analysts covering Verizon Communications Inc. (NYSE:VZ), 15 have Buy rating, 0 Sell and 16 Hold. Therefore 48% are positive. Verizon Communications Inc. had 84 analyst reports since July 22, 2015 according to SRatingsIntel. Moffett Nathanson upgraded the shares of VZ in report on Tuesday, February 21 to “Buy” rating. The rating was maintained by Cowen & Co on Tuesday, July 18 with “Hold”. On Tuesday, April 5 the stock rating was initiated by Macquarie Research with “Neutral”. The rating was upgraded by Barclays Capital on Monday, April 23 to “Overweight”. RBC Capital Markets maintained Verizon Communications Inc. (NYSE:VZ) on Wednesday, September 30 with “Outperform” rating. RBC Capital Markets maintained the stock with “Hold” rating in Friday, May 26 report. The stock of Verizon Communications Inc. (NYSE:VZ) earned “Hold” rating by SunTrust on Tuesday, January 23. The rating was maintained by RBC Capital Markets on Wednesday, January 24 with “Hold”. The firm earned “Hold” rating on Thursday, August 10 by Oppenheimer. Argus Research downgraded the stock to “Hold” rating in Friday, April 21 report.

Investors sentiment increased to 1.02 in 2017 Q4. Its up 0.14, from 0.88 in 2017Q3. It improved, as 57 investors sold VZ shares while 662 reduced holdings. 141 funds opened positions while 592 raised stakes. 2.54 billion shares or 0.48% more from 2.53 billion shares in 2017Q3 were reported. Timber Hill Limited Liability holds 0.03% or 7,879 shares in its portfolio. First Commercial Bank Sioux Falls stated it has 6,258 shares or 1.1% of all its holdings. Perigon Wealth Mngmt Ltd holds 757 shares or 0.01% of its portfolio. Covington Advisors invested 1.06% in Verizon Communications Inc. (NYSE:VZ). Segall Bryant Hamill Ltd Co owns 131,668 shares for 0.15% of their portfolio. Cognios Cap Ltd Company invested 0.75% in Verizon Communications Inc. (NYSE:VZ). 57,279 are owned by Koshinski Asset Mngmt. Gyroscope Mngmt Limited Liability Co holds 0.19% in Verizon Communications Inc. (NYSE:VZ) or 7,671 shares. 25,753 are held by Windward Capital Ca. Stonebridge Cap Advsr Ltd Liability Com has 99,074 shares. Van Strum & Towne owns 22,770 shares. Benchmark Capital Advisors holds 0.26% of its portfolio in Verizon Communications Inc. (NYSE:VZ) for 6,349 shares. Parametric Port Associate Lc reported 0.52% in Verizon Communications Inc. (NYSE:VZ). 95,024 are owned by Old Point And Svcs N A. Todd Asset Management Ltd Co stated it has 0.4% in Verizon Communications Inc. (NYSE:VZ).

More important recent ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) news were published by: Seekingalpha.com which released: “ANI Pharmaceuticals buying assets from Amneal, Impax” on April 27, 2018, also Benzinga.com published article titled: “Benzinga’s Daily Biotech Pulse: Valeant Earnings, Lipocine’s FDA Watch, Invivo CFO Departure”, Globenewswire.com published: “Market Trends Toward New Normal in Viacom, Nutanix, ANI Pharmaceuticals, PACCAR, Cabot Oil & Gas, and Box …” on May 07, 2018. More interesting news about ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) was released by: Streetinsider.com and their article: “ANI Pharma (ANIP) Agrees to Acquire Generic Products & Other Assets from Amneal Pharmaceuticals LLC and Impax …” with publication date: April 29, 2018.

Weiss Asset Management Lp, which manages about $1.80B and $1.15B US Long portfolio, upped its stake in Vertex Pharmaceuticals Inc (NASDAQ:VRTX) by 2,145 shares to 3,808 shares, valued at $571,000 in 2017Q4, according to the filing. It also increased its holding in Hennessy Cap Acquston Corp I by 1.22M shares in the quarter, for a total of 1.52 million shares, and has risen its stake in Actua Corp (NASDAQ:ACTA).

Analysts await ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) to report earnings on August, 2. They expect $1.21 EPS, up 37.50% or $0.33 from last year’s $0.88 per share. ANIP’s profit will be $14.26M for 13.31 P/E if the $1.21 EPS becomes a reality. After $1.23 actual EPS reported by ANI Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts -1.63% negative EPS growth.

Among 6 analysts covering ANI Pharma (NASDAQ:ANIP), 3 have Buy rating, 0 Sell and 3 Hold. Therefore 50% are positive. ANI Pharma had 20 analyst reports since July 31, 2015 according to SRatingsIntel. On Monday, October 16 the stock rating was maintained by Canaccord Genuity with “Buy”. The company was maintained on Thursday, November 2 by Roth Capital. On Friday, August 5 the stock rating was maintained by Oppenheimer with “Outperform”. The firm has “Buy” rating given on Thursday, December 7 by Canaccord Genuity. The firm has “Hold” rating given on Tuesday, May 24 by Standpoint Research. The stock of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) has “Buy” rating given on Wednesday, September 2 by TheStreet. The firm has “Neutral” rating given on Wednesday, February 22 by TH Capital. The firm has “Perform” rating by Oppenheimer given on Tuesday, July 19. The stock has “Buy” rating by Roth Capital on Monday, September 28. The company was maintained on Wednesday, February 28 by Canaccord Genuity.

Investors sentiment decreased to 1.09 in 2017 Q4. Its down 0.60, from 1.69 in 2017Q3. It dropped, as 13 investors sold ANIP shares while 43 reduced holdings. 23 funds opened positions while 38 raised stakes. 6.25 million shares or 0.89% less from 6.31 million shares in 2017Q3 were reported. Bnp Paribas Arbitrage Sa, New York-based fund reported 3,472 shares. Parkside National Bank And owns 6 shares or 0% of their US portfolio. Morgan Stanley holds 0% of its portfolio in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) for 40,289 shares. Legal And General Group Public Limited Company invested in 0% or 16,141 shares. Ls Invest Advsrs Limited Com holds 0.01% of its portfolio in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) for 1,704 shares. Envestnet Asset Inc invested 0% in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP). Violich Cap has invested 0.07% in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP). Kbc Group Nv, Belgium-based fund reported 16,057 shares. Pnc Financial Service reported 1,083 shares. Weiss Asset Management Lp has invested 0.07% of its portfolio in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP). Cortina Asset Limited Liability Corporation holds 0.27% of its portfolio in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) for 94,508 shares. Mark Sheptoff Planning Llc owns 0.17% invested in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) for 4,050 shares. Vanguard Group Inc has 0% invested in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP). Consonance Cap Lp owns 142,978 shares. Invest Counselors Of Maryland Ltd Liability Co invested in 0.2% or 61,412 shares.

Since March 1, 2018, it had 0 insider buys, and 10 sales for $18.16 million activity. The insider PRZYBYL ARTHUR sold 23,986 shares worth $1.47M. Marken James G. sold 4,177 shares worth $258,640. $1.77M worth of stock was sold by Schrepfer Robert W on Thursday, March 1. Shares for $439,047 were sold by RAYNOR DANIEL on Thursday, March 15.

Verizon Communications Inc. (NYSE:VZ) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Ellis Scott

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: